US20120022091A1 - Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof - Google Patents

Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof Download PDF

Info

Publication number
US20120022091A1
US20120022091A1 US13/145,783 US201013145783A US2012022091A1 US 20120022091 A1 US20120022091 A1 US 20120022091A1 US 201013145783 A US201013145783 A US 201013145783A US 2012022091 A1 US2012022091 A1 US 2012022091A1
Authority
US
United States
Prior art keywords
compound
formula
rosuvastatin
process
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/145,783
Inventor
Zdenko Casar
Janez Kosmrlj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP091518811 priority Critical
Priority to EP09151881A priority patent/EP2264015A1/en
Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd
Priority to PCT/EP2010/051163 priority patent/WO2010086438A1/en
Assigned to LEK PHARMACEUTICALS D.D. reassignment LEK PHARMACEUTICALS D.D. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CASAR, ZDENKO, KOSMRLJ, JANEZ
Publication of US20120022091A1 publication Critical patent/US20120022091A1/en
Application status is Abandoned legal-status Critical

Links